Photoacoustic molecular imaging for in vivo liver iron quantitation by Maccarinelli, Federica et al.
Photoacoustic molecular imaging for





Federica Maccarinelli, Fernando Carmona, Maria Regoni, Paolo Arosio, “Photoacoustic molecular imaging
for in vivo liver iron quantitation,” J. Biomed. Opt. 21(5), 056008 (2016), doi: 10.1117/1.
JBO.21.5.056008.
Photoacoustic molecular imaging for in vivo
liver iron quantitation
Federica Maccarinelli, Fernando Carmona, Maria Regoni, and Paolo Arosio*
University of Brescia, Department of Molecular and Translational Medicine, Laboratory of Molecular Biology, Viale Europa 11, Brescia 25123, Italy
Abstract. A recent study showed that ferritin is a suitable endogenous contrast agent for photoacoustic molecu-
lar imaging in cultured mammalian cells. We have therefore tested whether this imaging technique can be used
for in vivo quantification of iron in mouse livers. To verify this hypothesis, we used multispectral optoacoustic
tomography (MSOT) to image albino CD1 mice before and after experimental iron loading. Postmortem assays
showed that the iron treatment caused a 15-fold increase in liver iron and a 40-fold increase in liver ferritin levels,
while in vivo longitudinal analysis using MSOT revealed just a 1.6-fold increase in the ferritin/iron photoacoustic
signal in the same animals. We conclude that MSOT can monitor changes in ferritin/iron levels in vivo, but its
sensitivity is much lower than that of ex vivo iron assays.© 2016 Society of Photo-Optical Instrumentation Engineers (SPIE) [DOI: 10
.1117/1.JBO.21.5.056008]
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1 Introduction
Noninvasive in vivo evaluation of tissue iron concentration in
animal models is important for the study of iron-related disor-
ders and their treatments.1 Presently, magnetic resonance imag-
ing (MRI) is the gold standard technique for tissue iron
quantification in vivo. It measures iron indirectly by its effect
on the T1, T2, and T2 relaxation times of water.2 Since most
of the nonheme iron deposited in the tissues is stored inside the
ferritin, and ferritin can be detected by photoacoustic devices, it
was recently proposed by the use of photoacoustic molecular
imaging (PMI) techniques to detect endogenous ferritin in
vivo.3 Multispectral optoacoustic tomography (MSOT) is
emerging as a powerful noninvasive PMI technique for resolv-
ing tissue chromophores at the high spatial resolution provided
by ultrasound detection,4,5 thus becoming an alternative tech-
nique for in vivo imaging in small animals.4 The method is
based on the measure of the acoustic waves generated by the
thermoelastic expansion of the environment surrounding mole-
cules that absorb an electromagnetic radiation. The amplitude of
the generated acoustic waves depends on the optical absorption
profile of the tissue.6 When the emitted acoustic waves reach an
ultrasound detector, they can be combined for the reconstruction
of high-resolution images deep in tissue, since ultrasonic scat-
tering is about two to three orders of magnitude weaker than
optical scattering.7,8 In vivo, the system needs probes that absorb
in the near-infrared (NIR) region, as these wavelengths are able
to penetrate through the tissues up to 1 cm deep. For example,
oxy- and deoxy-hemoglobin are important endogenous chromo-
phores with absorption bands in the NIR region that have been
used to monitor blood flow and angiogenesis using photoacous-
tic approaches.9 Other endogenous photoacoustic probes present
in vivo include melanin, bilirubin, and lipids.10 Melanin is
located in the skin of nonalbino mice, bilirubin can be detected
in the lumen of the intestine, and lipids show a photoacoustic
signal at wavelengths above 900 nm. Recently, it was shown
that ferritin overexpressed in cultured cells can be monitored
by PMI due to its capacity to form an iron core that absorbs
in the infrared region.3 This observation prompted us to verify
whether ferritin can also be used as an in vivo endogenous
probe, based on the fact that ferritin evaluation gives a reliable
index of iron loading because its expression is strongly stimu-
lated by iron, particularly in the liver.11 In the present work, we
used MSOT to detect and quantify liver ferritin/iron accumula-
tion in vivo in mice before and after experimental iron loading.
2 Materials and Methods
2.1 Multispectral Optoacoustic Tomography
All MSOT experiments were performed using an inVision-128
small animal scanner (iThera Medical GmbH, Munich,
Germany). The excitation laser produces light pulses in the
NIR range (680 to 980 nm) at a repetition rate of 10 Hz and
the acoustic waves generated are detected by a 270-deg ultra-
sound transducer array with a central frequency of 5 MHz, suit-
able for imaging at depth required for an entire mouse cross
section. The transducer has a center frequency of 5 MHz 10%
and a bandwidth of >60% in receive mode only. This allows
practical acquisition of signals between 50 kHz and 7 MHz
and provides an in-plane spatial resolution of 165 μm. There
is an impulse response correction, and the data are further fil-
tered to keep only the range 10 KHz to 10 MHz. During image
acquisition, the artificial devices or mice were moved through
the transducer array to capture the corresponding transverse
image slices. Multispectral data analysis occurs in two regimes:
online (during acquisition) and offline (postprocessing). The
online analysis depends on the real-time backprojection
reconstruction algorithm. Further, it uses the linear regression
algorithm for spectral unmixing to resolve individual compo-
nents from different chromophores in the system. For each
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pixel in the image, the method fits the total measured optoacous-
tic spectrum to the known absorption spectra of the individual
chromophores, based on least-squares linear regression.12
2.1.1 Phantom
Phantoms used in this study are artificial devices that simulate
the shape, size, and optical properties of mouse body in imaging
techniques. They were made of 1.5% agar, 1% lipid content13,14
with 2 cm in diameter holding two inner channels (3-mm diam-
eter) with the sample and the control placed separately in two
transparent plastic straws (volume ∼250 μL). No absorbent
was added to the phantom mixture to better mimic in vivo tis-
sues. Twofold serial dilutions of iron (iron-dextran solution
12.5 mg∕mL, Sigma) and ferritin (ferritin from horse spleen
0.38 mg∕mL, Sigma) were inserted in scattering agar phantoms
using water as control. Phantoms were scanned at excitation
wavelengths from 680 to 980 nm with a stepwise increment
of 10 nm using three average frames per illumination wave-
length then averaged to create a single image. MSOTacquisition
was performed in three transverse planes (∼800 μm cross sec-
tion) with a step size of 2 mm across the phantom. For quanti-
tative calculation, the iron/ferritin photoacoustic signal was
obtained from the region of interest (ROI) area drawn in corre-
spondence of the samples using the transverse photoacoustic
images provided by ViewMSOT™ 3.6 software.
2.1.2 Mice and iron treatment
All the procedures followed animal protection laws and institu-
tional guidelines of the European Convention for the Protection
of Laboratory Animals. The study was approved by the
Institutional Animal Care and Use Committee of the University
of Brescia and the Italian Ministry of Science and Research. We
used six female CD1 albino background mice that were 5 weeks
old. A group of three mice was treated intraperitoneally with
5 mg of iron (iron-dextran solution, Sigma) twice a week for
three consecutive weeks and three control mice were treated
with saline in the same way. MSOT acquisition was performed
for all the mice before the treatment and every week 2 days after
the second weekly injection. The animals were anesthetized for
all imaging procedures by general isoflurane anesthesia (1.8% to
2.0% at 0.8 L∕min). The anesthetized mice were shaved and
their skin surface was covered with an ultrasound gel, then
they were placed in the instrument in horizontal position and
wrapped in a thin polyethylene membrane. Imaging was per-
formed on transverse slices with a step size of 0.5 mm from
the end of the rib cage to the end of the kidneys using 20 average
frames per illumination wavelength at 700, 730, 760, 800, and
850 nm to obtain a spectral unmixed image of a cross section
every 10 s. Averaging pertains to the number of sequential laser
pulses that are “averaged” into a single data point before the
laser continues to the next defined wavelength. In principle,
averaging increases the contrast-to-noise ratio for a given
acquisition or to account for motion, but averaging is also a
determinant of temporal resolution. For most in vivo applica-
tions, using 20 averages is a good compromise between increas-
ing contrast to noise as well as accounting for motion related to
breathing (typically 1 Hz) on the one side and good temporal
resolution on the other side. For anatomical localization of the
signal, the transverse photoacoustic images at 850 nm were
compared with the mouse atlas provided by ViewMSOT™
3.6 software. For quantitative calculation of the ferritin/iron




Mice were anesthetized with Avertine (23-μL∕gmouse; Sigma),
sacrificed, and perfused with a physiological saline solution
containing 2% heparin; tissue samples were then removed and
lysed in ice-cold lysis buffer (20-mM Tris buffer, pH 7.4, 1%
Triton X-100, 1-mM sodium azide, 1-mM PMSF, 10-mM
leupeptin, and 1-mM pepstatin) using a Potter homogenizer.
The homogenates were clarified by centrifugation at 10,000 g
for 10 min at 4°C, and the supernatant proteins were quantified
by Bradford assay (Biorad).
2.2.2 Ferritin immunoblot
Protein extracts (30 μg) were separated by 12% sodium dodecyl
sulfate polyacrylamide gel electrophoresis and transferred onto
nitrocellulose membranes (GE Healthcare). Immunoblotting
was performed using specific primary antibodies antiferritin
(Sigma) and anti-GAPDH (Sigma). After incubation with horse-
radish peroxidase-conjugated secondary antibodies, the bands
were revealed by enhanced chemiluminescence (ECL from GE
Healthcare) and quantified by densitometry analysis using
ImageJ software.
2.2.3 Iron assay
Photometric iron evaluation was done as described in Ref. 15.
Briefly, 50 mg of liver tissue were digested in an acidic solution
(HCl 3 M and trichloroacetic acid 0.6 M) at 65°C for 16 h. Then,
samples were clarified by centrifugation and 10 μL of the super-
natant were added to 240 μL of working chromogen reagent
(0.01% bathophenanthroline and 0.1% thioglycolic acid in
45% sodium acetate). The solutions were then incubated for
30 min at room temperature until color development and the
absorbance measured at 535 nm.
Fig. 1 NIR absorption spectra of ferritin, Hb, and HbO2. The absorp-
tion and the photoacoustic spectra of ferritin and Hb in the 680 to
900 nm range are similar with the exception of an Hb peak at
760 nm, while the HbO2 spectrum shows a wide absorption peak
at higher wavelengths.
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3 Results and Discussion
Ferritin photoacoustic properties were recently analyzed in vitro
in cells3 in the absence of hemoglobin (Hb) and oxygenated
hemoglobin (HbO2), the two main endogenous iron-containing
in vivo photoacoustic absorbers.16 Thus, we started comparing
the photoacoustic properties of iron-loaded ferritin with those of
the Hbs. The absorption spectra of ferritin and Hb in the 680 to
900 nm range are similar with the exception of an Hb peak at
760 nm, while the HbO2 spectrum shows a wide absorption
peak at higher wavelengths (Fig. 1).
For signal deconvolution, the ViewMSOT™ 3.6 software
provided by the inVision-128 small animal scanner uses a linear
algorithm. Unmixing the ferritin signal from that of HbO2 does
not pose problems, while the unmixing from that of Hb may
suffer of some limitations, since it is based only on the differ-
ence at 760 nm between their absorption spectra. Then, to verify
whether ferritin/iron can be monitored by MSOT using our
equipment (inVision-128 small animal scanner), twofold serial
dilutions of ferritin and iron dextran were loaded in a scattering
and nonabsorbing tissue-mimicking phantom device using
water as the control reference. In the concentration range com-
patible with that expected in some tissues of living mice (95 to
380 μg∕mL),17 the MSOT signal obtained was positively related
to the loaded concentration of ferritin (Fig. 2) and iron (data not
shown). The relationship between the photoacoustic signal
Fig. 2 Photoacoustic properties of ferritin/iron. (a) Photoacoustic
tomographically reconstructed images. Ferritin dilutions were inserted
in a scattering and nonabsorbing tissue-mimicking phantom device
using water as control. (b) Photoacoustic signal quantification of ferri-
tin. The ferritin/iron photoacoustic signal was obtained from the ROI
area drawn in correspondence of the samples using the transverse
photoacoustic images provided by ViewMSOT™ 3.6 software. The
graph shows the relationship between the MSOT signal and the ferri-
tin concentration (95 to 380 μg∕mL).
Fig. 3 In vivo photoacoustic tomographically reconstructed image of a transverse slice of an untreated
mouse. (a) The grayscale image represents a single wavelength (850 nm) and was used as background
for the anatomical localization of the signal. The colored scale shows the ferritin/iron photoacoustic
signal. All the mice show a stronger ferritin signal (1) in the liver and (2) in the spleen. On the contrary,
no ferritin absorbance was detected (3) in the kidneys. (b) Corresponding transverse image of the
mouse atlas provided by ViewMSOT™ 3.6 software.
Fig. 4 Analysis of the iron-treated and untreated mice. (a) The skin
color of the shaved mice after the 3-week iron treatment was darker
than that of the controls. (b) After the sacrifice, tissue samples were
collected for biochemical analysis. A darker color in the liver of iron-
treated mice is evident compared to the controls, while the color of
the kidney is similar, indicating the correct perfusion of the animals.
(c) Photometric iron evaluation shows a 15-fold increase of the liver
nonheme iron concentration in the treated mice. (d) Immunoblotting
on liver protein extracts, performed using the specific primary anti-
body, shows a 40-fold ferritin increase in iron-loaded mice.
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obtained with the MSOT and the ferritin/iron concentration
supported the possibility to use ferritin as an endogenous photo-
acoustic contrast agent in vivo in mice.
Next, we analyzed six untreated mice of the CD1 albino
background using the settings for ferritin/iron detection. The
anatomical localization of the signal was obtained comparing
the photoacoustic background image at 850 nm, where no
ferritin/iron photoacoustic signal is present, with the corre-
sponding transverse image of the mouse atlas provided by
the ViewMSOT™ 3.6 software. This allowed precise drawing
of ROI areas over the liver, spleen, and other organs, for the
quantitation of the photoacoustic signal. An evident ferritin/
iron photoacoustic signal was found in correspondence of the
liver and spleen (Fig. 3), which are the major iron storage
organs, but was not found in the kidneys and the heart (data
not shown).
This result suggested that ferritin/iron could be quantified in
the liver of living mice by photoacoustic analysis. To verify this,
three CD1 mice were treated intraperitoneally (IP) with iron-
dextran solution (5 mg∕IP, twice a week for three consecutive
weeks) to induce iron overload, while the other three control
mice were treated in the same way with saline solution. The
skin color of the shaved iron-loaded mice at the end of the
treatment was darker than that of the saline-treated ones (Ctrl)
[Fig. 4(a)], and after the sacrifice the liver of iron-treated mice
showed a color remarkably stronger than that of the matched
controls [Fig. 4(b)].
In addition, postmortem analyses showed that nonheme iron
content in liver was 15-fold higher in iron-treated mice com-
pared to the controls [Fig. 4(c)], and the ferritin level measured
by western blotting was about 40-fold above the basal level
[Fig. 4(d)]. Altogether, the biochemical analyses confirmed
that the iron treatment was effective and induced a massive
iron loading in the liver. MSOT acquisition was performed for
all the mice before, during, and at the end of the treatment,
before the sacrifice. Figure 5 shows the MSOT cross sections
of the mice after the 3-week iron treatment.
A photoacoustic signal is evident in the ROI areas
drawn over the liver and spleen region confirming that the
ferritin/iron deposits are actually detected by the system in
Fig. 5 In vivo and ex vivo photoacoustic analysis of the liver of iron-loaded and control mice.
Photoacoustic tomographically reconstructed images of (d, e, f) iron-loaded mice show a stronger ferri-
tin/iron signal both in the liver (right ROI) and in the spleen (left ROI) compared to (a, b, c) saline-treated
mice. The gray-scale image taken at 850 nm was used for the anatomical localization of the signal. The
colored scale shows the ferritin/iron photoacoustic signal. (g) Quantitation of the ferritin/iron photoacous-
tic signal was obtained from the ROI areas drawn over the liver using the transverse photoacoustic
images provided by ViewMSOT™ 3.6 software. Themean photoacoustic signal of the liver of iron-treated
animals was 1.6-fold higher than that of the control ones. A similar signal dispersion is observed in the
iron-loaded mice before and after the treatment, while no differences are observed in the saline-treated
ones. The iron-loaded mice showed an increase of the ferritin/iron photoacoustic signal also in peripheral
areas in proximity of the liver and the spleen (yellow arrows). (h) Photoacoustic tomographically recon-
structed images. Liver homogenates of iron-loaded and control mice were inserted in a scattering and
nonabsorbing tissue-mimicking phantom. (i) Photoacoustic signal quantification of ferritin. The ferritin/
iron photoacoustic signal was obtained from the ROI area drawn in correspondence of the samples
using the transverse photoacoustic images provided by ViewMSOT™ 3.6 software. The graph shows
a signal 1.5-fold higher in the iron-loaded mice compared to the controls, a difference not statistically
significant.
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physiological conditions [Figs. 5(a), 5(b), and 5(c)]. A careful
quantification of the pixel intensity of the similar ROI areas
showed that the signal of the three control mice did not change
significantly during the period of the treatment, while that of the
iron-treated animals increased. In two mice it increased about
20%, and in one mouse it increased about 90%, with a mean
signal 1.6-fold higher in the iron-loaded mice compared to
the controls, a statistically insignificant difference [Fig. 5(g)].
A similar increase in the photoacoustic signal was also found
analyzing the liver homogenates inserted in an agar phantom
[Fig. 5(h)]. The iron-loaded mice showed an increase of the
ferritin/iron photoacoustic signal also in peripheral areas in
proximity of the liver and the spleen [Figs. 5(d), 5(e), and
5(f) yellow arrows], which was attributed to the skin and prob-
ably not directly linked to the iron overload. We are not aware
that iron overload may cause an accumulation of iron or NIR
probes in the skin; thus, further experiments are needed to verify
the reasons leading to an increase of the photoacoustic signal in
the skin after iron treatment.
In conclusion, we found that although MSOT can detect in
vivo ferritin/iron overload in mice liver and spleen, its sensitivity
is far too low for many applications, and is not comparable to
that of postmortem analyses. Therefore, it seems to us unlikely
that photoacoustic tomography could replace MRI for in vivo
analysis of iron status in mice using endogenous ferritin as a
photoacoustic reporter. The low sensitivity of MSOT in this
study may be due to the low ferritin/iron absorbance in the
NIR region compared to the high background signal given by
Hb, which interferes with that of the ferritin.
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